AI model aims to end guesswork in head and neck cancer care

NCT ID NCT07532928

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Nanfang Hospital, Southern Medical University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study uses an AI model to analyze patient data and recommend the best follow-up treatment after surgery for advanced head and neck cancer. Researchers will track 571 patients over two years to see if the AI's suggestions improve survival and reduce recurrence. The goal is to move away from one-size-fits-all treatment and offer truly personalized care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI decision model
What this could lead to: If successful, this could help doctors choose the best post-surgery treatment for each head and neck cancer patient, potentially improving survival and reducing side effects.
What could go wrong: This is an observational study using existing data, not a controlled trial. The AI model may not work for all patients, and results may not apply outside the study hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP LEARNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP LEARNING HEAD & NECK SQUAMOUS CELL CARCINOMA

Contacts and locations

Locations

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University

Guangzhou, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.